On this week's episode, we welcome Bek Muslimov & Nikolay Tretiyakov, Co-Founders of Leafy Tunnel - early stage VC firm investing in psychedelics and cannabis to combat mental health and pain disorders.
We examine the European investment landscape within the psychedelic and cannabis sector, looking into the types of investors and funds operational within this space, alongside how they have changed as the market begins to build momentum.
→ View full show notes, summary, and access resources here:
https://www.canverse.global/shownotes/e138
About Nikolay Tretiyakov
Nikolay is a Co-Founding Partner at Leafy Tunnel. Nikolay is an investor in ATAI Life Sciences (a biotech platform curing mental health disorders) and Iuvo Therapeutics (a European cannabis company).
Prior to Leafy Tunnel, in 2013 Nikolay founded Blue Wire Capital, a multi-strategy investment firm investing in European venture funds, technology and life science companies.
Nikolay holds a BA degree from the University of Wolverhampton and an MBA from the Russian Academy of National Economy.
About Bek Muslimov
Bek is a Co-Founding Partner at Leafy Tunnel. For the past 7 years, he has been investing in European technology and life science companies. His recent investments include ATAI Life Sciences and Iuvo Therapeutics.
Prior to Leafy Tunnel, Bek was the Investment Director at Blue Wire where he led investments in Monzo, Superawesome, Homehero, Ocean Harvest, and Ihateironing
Bek is an MBA graduate of London Business School, has completed a medical neuroscience course at Duke University and holds a medical cannabis specialisation from the University of Colorado Boulder.
Resources
Leafy Tunnel’s Website: https://www.leafytunnel.com/
Join Bek on LinkedIn: https://www.linkedin.com/in/bekmuslimov/
Join Nikolay on LinkedIn: https://www.linkedin.com/in/nikolaytretyakov/
Follow Leafy Tunnel on LinkedIn: https://www.linkedin.com/company/leafy-tunnel/